[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339349-105":59,"doc-detail-339349-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","inflammasome-related-gene-signatures-as-prognostic-biomarkers-in-osteosarcoma","Inflammasome-related gene signatures as prognostic biomarkers in osteosarcoma","","Osteosarcoma, the primary bone cancer in adolescents and young adults, shows aggressive growth and a high metastatic potential. The study evaluates the prognostic value of inflammasome-related gene signatures using comprehensive genetic profiling. Consensus clustering defines three patient subgroups with distinct survival outcomes and immune infiltration patterns. A machine learning prognostic model (c-index 0.706) highlights CD36 and MYD88, and higher risk scores predict poorer survival across datasets. In vitro assays confirm roles in proliferation, invasion, and migration.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/inflammasome-related-gene-signatures-as-prognostic-biomarkers-in-osteosarcoma/339349/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/inflammasome-related-gene-signatures-as-prognostic-biomarkers-in-osteosarcoma/339349.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main aim of the study on osteosarcoma?","Question",{"text":112,"@type":113},"To determine how inflammasome-related gene signatures can predict patient prognosis in osteosarcoma and to identify key biomarkers linked to outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were patient subgroups defined?",{"text":117,"@type":113},"The study used consensus clustering based on genetic profiling to divide patients into three subgroups with different survival and immune infiltration characteristics.",{"name":119,"@type":110,"acceptedAnswer":120},"Which genes and model outputs were identified as key prognostic signals?",{"text":121,"@type":113},"Machine learning produced a prognostic model highlighting CD36 and MYD88 as key genes, and higher inflammasome risk scores were associated with worse survival, validated across datasets.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339349,1790396630,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","DOI: 10. 1111/jcmm.18286  \nOR I G I NAL ART I C L E  \nInflammasome-related gene signatures as prognostic biomarkers in osteosarcoma  \nNan Zhang1 | Ying Han2,3 | Hangkai Cao4 | Qingxin Wang4   \n1Department of Medical Oncology, China Coast Guard Hospital of the People's Armed Police Force, Zhejiang, China 2Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Zhejiang, China  \n3 Key Laboratory of Musculoskeletal System Degeneration and Regeneration Translational Research of Zhejiang Province, Zhejiang, China 4Department of Orthopaedic Surgery, China Coast Guard Hospital of the People's Armed Police, Zhejiang, China  \nCorrespondence  \nQingxin Wang, Department of Orthopaedic Surgery, China Coast Guard Hospital of the People's Armed Police, Zhejiang, China. [Email:](Email: wz1014714@163.com)[ wz1014714@163.com](Email: wz1014714@163.com)  \nFunding information  \nJiaxing People's Livelihood Science and Technology Innovation Research Project Fund, Grant/Award Number:  \nSQGY202300254; Science and Technology Bureau of Jiaxing City, Grant/ Award Number: 2023AY31017  \nAbstract  \nOsteosarcoma, the primary bone cancer in adolescents and young adults, is notorious for its aggressive growth and metastatic potential. Our study delved into the prognostic impact of inflammasome-related gene signatures in osteosarcoma patients, employing comprehensive genetic profiling to uncover signatures linked with patient outcomes. We identified three patient subgroups through consensus clustering, with one showing worse survival rates correlated with high FGFR3 and RARB expressions. Immune profiling revealed significant immune cell infiltration differences among these subgroups, affecting survival. Utilising advanced machine learning, including StepCox and gradient boosting machine algorithms, we developed a prognostic model with a notable c-index of 0 .706, highlighting CD36 and MYD88 as key genes. Higher inflammasome risk scores from our model were associated with poorer survival, corroborated across datasets. In vitro experiments validated CD36 and MYD88's roles in promoting osteosarcoma cell proliferation, invasion and migration, emphasising their therapeutic potential. This research offers new insights into inflammasomes' role in osteosarcoma, introducing novel biomarkers for risk assessment and potential therapeutic targets. Our findings suggest a pathway towards personalised treatment strategies, potentially improving patient outcomes in osteosarcoma.  \nK E Y WO R D S  \ngene signatures, immune profiling, inflammasomes, osteosarcoma, prognostic biomarkers  \n1 | INTRODUCTION  \nOsteosarcoma, the most prevalent malignant bone tumour in paediatric populations, presents a stark embodiment of cancer's ruthless disregard for life's potential.1,2 This aggressive disease typically strikes in the bloom of youth, interrupting the lives of adolescents as they stand on the cusp of adulthood. 3,4 Despite remarkable progress in cancer research, the overall survival rate for osteosarcoma has plateaued over the past few decades, especially for those with metastatic disease at diagnosis.5–7 The stagnation of therapeutic  \nadvancements underscores an urgent need for novel approaches in understanding and treating this malignancy. 8,9  \nThe battle against osteosarcoma is fought on a molecular frontier, where the identification of key genetic and immunologic factors holds the promise of turning the tide in patient outcomes.10,11 Recent scientific inquiries have directed a spotlight onto inflammasomes—complexes involved in the innate immune response—as pivotal players in the cancer saga.11,12 These inflammasomes, which orchestrate a cascade of inflammatory responses, have emerged as double-edged swords within the tumour microenvironment.13,14  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is ","cbCaiaiQe8znzMdx","https://ap.wps.com/l/cbCaiaiQe8znzMdx","pdf",15529773,"English","# Abstract\n# Introduction","[{\"question\":\"What is the main aim of the study on osteosarcoma?\",\"answer\":\"To determine how inflammasome-related gene signatures can predict patient prognosis in osteosarcoma and to identify key biomarkers linked to outcomes.\"},{\"question\":\"How were patient subgroups defined?\",\"answer\":\"The study used consensus clustering based on genetic profiling to divide patients into three subgroups with different survival and immune infiltration characteristics.\"},{\"question\":\"Which genes and model outputs were identified as key prognostic signals?\",\"answer\":\"Machine learning produced a prognostic model highlighting CD36 and MYD88 as key genes, and higher inflammasome risk scores were associated with worse survival, validated across datasets.\"}]","Inflammasome-related gene signatures as prognostic biomarkers in osteosarcoma | PDF",1790029765,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/52dab532fe6ce2898dc39b8105d2a067.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/256c8cb70bd4ab2a40df4ba92b80fb5a.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/489625ff2687ad54c8c7788992bf5078.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fdb09342dde620b0e590fdcff43634a2.webp",980,1287]